Johnson & Johnson (JNJ) Takes New Approach to Innovation
Get Alerts JNJ Hot Sheet
Price: $147.91 +1.49%
Overall Analyst Rating:
NEUTRAL ( Up)
Dividend Yield: 3.4%
EPS Growth %: +1.1%
Overall Analyst Rating:
NEUTRAL ( Up)
Dividend Yield: 3.4%
EPS Growth %: +1.1%
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) today announced plans to establish four regional innovation centers in major life sciences communities in the world as part of a novel approach to accelerate early innovation and enhance opportunities for collaboration and investment across its global healthcare businesses.
Targeted to open in some of the world's leading innovation hotspots in California, Boston, London and China, the Johnson & Johnson innovation centers will serve as regional hubs focused on identifying early-stage innovations, and establishing novel collaborations to invest in and speed development of those innovations to solve unmet needs in patients. Each innovation center will house science and technology experts and have local deal-making capabilities, with flexibility to adapt deal structures to match the early-stage opportunity.
Targeted to open in some of the world's leading innovation hotspots in California, Boston, London and China, the Johnson & Johnson innovation centers will serve as regional hubs focused on identifying early-stage innovations, and establishing novel collaborations to invest in and speed development of those innovations to solve unmet needs in patients. Each innovation center will house science and technology experts and have local deal-making capabilities, with flexibility to adapt deal structures to match the early-stage opportunity.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Upgrades Johnson & Johnson (JNJ) to Buy, 'Steady outlook, low expectations'
- Mondi Says It Does Not Intend To Make An Offer For DS Smith
- Johnson & Johnson (JNJ) PT Lowered to $176 at DZ Bank
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!